Merck & Co Inc. (NYSE:MRK) said a comprehensive review it undertook showed that its controversial feed additive Zilmax was safe when used according to its product label. Merck suspended sales of Zilmax in the United States and Canada in August last year following concerns about animals showing signs of distress after use of the weight-gain product. Merck & Co. Inc. (NYSE:MRK) belongs to Healthcare sector. Its net profit margin is 12.50% and weekly performance is 6.00%. On last trading day company shares ended up $59.57. Merck & Co. Inc. (NYSE:MRK) distance from 50-day simple moving average (SMA50) is 1.74%. Cemex, S.A.B. de C.V. (NYSE:CX) has received US$515 million of commitments from banks that have agreed to join the credit agreement entered into on 30 September 2014. Following the completion of customary closing conditions, the banks that provided the new commitments will accede the credit agreement as additional lenders, increasing the total amount from US$1.35 billion to US$1.87 billion. CEMEX, S.A.B. de C.V. (NYSE:CX) shares moved down -0.98% in last trading session and ended the day at $12.15. CX Gross Margin is 31.50% and its return on assets is -1.70%. CEMEX, S.A.B. de C.V. (NYSE:CX) quarterly performance is -2.25%. CAE Inc. (NYSE:CAE) has earned an average rating of “Buy” from the thirteen brokerages that are covering the stock. Four equities research analysts have rated the stock with a hold recommendation and eight have assigned a buy recommendation to the company. The average 12-month target price among brokers that have updated their coverage on the stock in the last year is $15.47. On 05 November, CAE Inc. (NYSE:CAE) shares moved up 1.08% and was closed at $13.05. CAE EPS growth in last 5 year was -0.60%. CAE Inc. (NYSE:CAE) year to date (YTD) performance is 3.82%. A better-ranked stock in the health care space is AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG), sporting a Zacks Rank #1 (Strong Buy). AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) ended the last trading day at $33.78. Company weekly volatility is calculated as 6.51% and price to cash ratio as 1.92. AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) showed a weekly performance of 1.56%. Wayne Savings Bancshares, Inc. (NASDAQ:WAYN) announced that the Board of Directors has appointed H. Stewart Fitz Gibbon III to the positions of President and Chief Executive Officer of the Company and the Bank, effective November 3, 2014. As announced on March 17, 2014, Rod C. Steiger, Director, President and Chief Executive Officer of the Company will retire on December 31, 2014. Wayne Savings Bancshares Inc. (NASDAQ:WAYN) shares moved up 0.79% in last trading session and ended the day at $12.75. WAYN return on assets is 0.60%. Wayne Savings Bancshares Inc. (NASDAQ:WAYN) quarterly performance is -0.08%.
Discover Hidden Gems
Don't miss the next big opportunity. Subscribe for timely alerts on potential market movers.
